RxDoctor Payments Data

Beatriz Colon

Emergency Medicine · Orlando, FLNPI 1457313496

Payments from drug & device makers

What this record shows

Alnylam Pharmaceuticals Inc. accounts for 78.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $1,244 and has fallen 75.0% since, to $311 in 2025. Among emergency medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,580in general payments, 2019–2025

Across 15 payments — averaging $105.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$1K
  • Bayer$311
  • Genentech USA, Inc.$25
$1,830,559in research payments, 2019–2025

Across 97 payments — averaging $18,872 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$722K
  • Genentech, Inc.$598K
  • AstraZeneca$224K
  • Madrigal Pharmaceuticals$84K
  • Hoffmann-la Roche Limited$79K
  • Boehringer Ingelheim International GmbH$57K
  • plus $67K from 5 others

What the payments were for

  • Travel & lodging$92659%
  • Food & beverage$65341%

General payments by program year

20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alnylam Pharmaceuticals Inc.9$1,244
Bayer5$311
Genentech USA, Inc.1$25

How this compares

$1,580 in reported general payments places this provider in the 95th percentile of 3,289 emergency medicine providers in Florida.

See all emergency medicine providers in Florida →

Other emergency medicine in Orlando

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →